Premium
Periodic acid‐Schiff stain as a prognostic indicator in serous and mucinous ovarian tumors
Author(s) -
Aalto MarjaLeena,
Collan Yrjó
Publication year - 1986
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(86)90020-2
Subject(s) - medicine , mucinous cystadenoma , serous cystadenocarcinoma , serous fluid , mucin , serous cystadenoma , stain , pathology , mucinous cystadenocarcinoma , pseudomyxoma peritonei , periodic acid–schiff stain , ovary , mucinous carcinoma , gastroenterology , adenocarcinoma , immunohistochemistry , appendix , staining , ovarian cancer , cancer , paleontology , biology
The prognostic significance of periodic acid‐Schiff (PAS) stain in 112 serous: 43 benign, 25 borderline and 44 malignant cystadenomas; and in 106 mucinous: 60 benign, 32 borderline and 14 malignant cystadenomas of the ovary were investigated. The amount of positively stained mucin was estimated morphometrically. The outcome of most patients with benign or borderline lesion was good. One patient with benign mucinous cystadenoma died, however, of pseudomyxoma peritonei and another patient with borderline mucinous cystadenoma died of peritoneal carcinosis. Other patients were alive and free of the disease after a follow‐up of 1–14 years, or had died of causes unrelated to the ovarian disease. Abundant PAS positive mucin predicted a longer survival both in serous and in mucinous malignant tumors. The 5‐year survivals for the serous cystadenocarcinomas with and without PAS positive mucin were 21% and 13%, respectively (not statistically significant). For mucinous cystadenocarcinomas with mucin value over and below the median, the 5‐year survival rates were 57% and 14%, respectively (P < 0.10). High PAS positivity in both serous and mucinous cystadenocarcinomas clearly indicated better prognosis, although statistical significance was not achieved. Thus, further studies are needed for final evaluation of the prognostic significance of the PAS stain in these ovarian tumors.